BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/20/2017 12:12:53 PM | Browse: 1327 | Download: 3050
 |
Received |
|
2017-01-03 14:39 |
|
Peer-Review Started |
|
2017-01-04 10:56 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2017-02-16 17:29 |
|
Revised |
|
2017-03-14 18:23 |
|
Publication Fee Transferred |
|
2017-04-05 07:14 |
|
Second Decision by Editor |
|
2017-03-28 16:48 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-03-31 08:03 |
|
Articles in Press |
|
2017-03-31 08:03 |
|
Edit the Manuscript by Language Editor |
|
2017-05-15 03:59 |
|
Typeset the Manuscript |
|
2017-06-08 12:22 |
|
Publish the Manuscript Online |
|
2017-06-20 12:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jie Feng, Bo Qi, Ling Guo, Ling-Yun Chen, Xiu-Feng Wei, Yu-Zhen Liu and Bao-Sheng Zhao |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Key Technologies R&D Program of Science and Technology Commission of Henan Province (to Zhao BS) |
152102310110 |
| Key Science and Technique Fund of Xinxiang (to Zhao BS) |
ZG15018 |
|
| Corresponding Author |
Bao-Sheng Zhao, MD, Professor of Surgery, Chief, Department of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, Henan Province, China. zhaobscn@126.com |
| Key Words |
miR-382; Esophageal squamous cell carcinoma; Tumor suppressor; Proliferation; Migration; Invasion |
| Core Tip |
Our previous study revealed that miR-382 was significantly down-regulated in esophageal squamous cell carcinoma (ESCC) patients with short-term motility, implying that miR-382 may display antitumor function in ESCC development and metastasis. We present here that miR-382 functions as a tumor suppressor by inhibiting proliferation, migration, invasion and epithelial-mesenchymal transition, in addition to inducing cell cycle arrest, apoptosis and autophagy in Eca109 cells. Inhibitory influence on protein translation mediated by mTOR/4E-BP1 signaling might be involved in the antitumor activity of miR-382 against ESCC. Thus, manipulation of miR-382 level can be a potentially therapeutic intervention for ESCC. |
| Publish Date |
2017-06-20 12:12 |
| Citation |
Feng J, Qi B, Guo L, Chen LY, Wei XF, Liu YZ, Zhao BS. miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(23): 4243-4251 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i23/4243.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i23.4243 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
